Taking an HPV vaccine research-tested intervention to scale in a clinical setting

Suellen Hopfer, Anne E. Ray, Michael L. Hecht, Michelle Miller-Day, Rhonda Belue, Gregory Zimet, W. Douglas Evans, Francis X. McKee

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Research tested interventions are seldom ready for wide spread use. Successful intervention adaptation to clinical settings demands an iterative process with target audience feedback. We describe the adaptation process of implementing an NCI research tested HPV vaccine intervention, Women's Stories, to a community clinic context (Planned Parenthood). Five phases are described for the adaptation of content and the development of a health kiosk intervention delivery system: (a) informant interviews with the target audience of young adult, predominantly African-American women, (b) translating HPV vaccine decision narratives into prevention messages, (c) health kiosk interface design, (d) conducting a usability study of the health kiosk intervention product, and (e) conducting a waiting room observational study. Lessons learned and challenges in adapting prevention interventions to clinical settings are discussed.

Original languageEnglish
Pages (from-to)745-752
Number of pages8
JournalTranslational Behavioral Medicine
Issue number5
StatePublished - Sep 8 2018

Bibliographical note

Publisher Copyright:
© Society of Behavioral Medicine 2018.


  • Adapting an Intervention
  • African American
  • Decision Narratives
  • Dissemination
  • HPV vaccine
  • Health Equity
  • Implementation

ASJC Scopus subject areas

  • Applied Psychology
  • Behavioral Neuroscience


Dive into the research topics of 'Taking an HPV vaccine research-tested intervention to scale in a clinical setting'. Together they form a unique fingerprint.

Cite this